Colitis, Ulcerative: all 1,530 studies

Page 9 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.

• Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)Active, not recruitingNCT05817942
• Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative ColitisWithdrawnNCT05809583
• An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in JapanCompletedNCT05791526
• Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative ColitisStatus unknownNCT05788549Not applicable
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative ColitisCompletedNCT05784246Phase 3
• Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.Active, not recruitingNCT05782907Phase 3
• Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)CompletedNCT05780723Not applicable
• Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®Active, not recruitingNCT05771155Phase 3
• Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative ColitisCompletedNCT05761327Not applicable
• Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative ColitisCompletedNCT05743153Not applicable
• A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative ColitisStatus unknownNCT05743010Phase 1
• Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative ColitisStatus unknownNCT05735665Not applicable
• A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))Active, not recruitingNCT05731128Phase 2
• Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.CompletedNCT05728008
• Role of Roflumilast in Ulcerative ColitisCompletedNCT05684484Phase 4
• Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative ColitisStatus unknownNCT05680883
• Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease StudyStatus unknownNCT05673278
• Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative ColitisTerminatedNCT05672199Phase 2
• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive, not recruitingNCT05668013Phase 2
• Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative ColitisCompletedNCT05662059Not applicable
• Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative ColitisCompletedNCT05656391Not applicable
• Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative ColitisStatus unknownNCT05653791
• The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel DiseaseWithdrawnNCT05652491
• Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative ColitisCompletedNCT05649462
• The Effectiveness of Well-being Therapy on Mental Health and Self-efficacy of Patients With Ulcerative ColitisCompletedNCT05645666Not applicable
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT05644665Phase 3
• Evaluation of the SIMBA Capsule for Small Intestinal DysbiosisActive, not recruitingNCT05633706
• the Efficacy and Safety of Diosmin in Patients With Ulcerative ColitisStatus unknownNCT05626166Phase 3
• A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in BrazilCompletedNCT05626088
• The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative ColitisStatus unknownNCT05606939
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisActive, not recruitingNCT05588843Phase 2
• Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 VaccineCompletedNCT05584735
• Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome SignaturesWithdrawnNCT05579483Not applicable
• Stem Cells for the Treatment of PouchitisWithdrawnNCT05578508Phase 1
• Nicotinamide Riboside in Ulcerative ColitisTerminatedNCT05561738Not applicable
• Metformin in Patients With Ulcerative Colitis Treated With MesalamineCompletedNCT05553704Phase 2
• A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative ColitisTerminatedNCT05549323Phase 1
• Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative ColitisWithdrawnNCT05539625Phase 2
• Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative ColitisCompletedNCT05538026Not applicable
• ABTECT - MaintenanceActive, not recruitingNCT05535946Phase 3
• Prognosis in UC After First BiologicalCompletedNCT05530122
• Broccoli Sprouts for Mild Ulcerative ColitisCompletedNCT05507931Not applicable
• Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center OsijekCompletedNCT05504915
• Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative ColitisActive, not recruitingNCT05496348
• Hepatobiliary Manifestations Following Two-Stages Elective Laparoscopic Restorative Proctocolectomy for Patients With Ulcerative Colitis. A Prospective Observational Study.CompletedNCT05495178
• An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World PracticeActive, not recruitingNCT05494606
• Anal Manometry Examination in Patients With Ulcerative ColitisStatus unknownNCT05488041Not applicable
• Health Benefits of Tart Cherry in Ulcerative ColitisCompletedNCT05486507Not applicable
• Health-related Physical Fitness in Patients with Inflammatory Bowel DiseaseCompletedNCT05482932
• Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)Active, not recruitingNCT05466890Phase 2
• FIT Combining FC for Predicting MH and Histology Remission in UCStatus unknownNCT05447572
• Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated SpondyloarthropathyStatus unknownNCT05431283
• NORDTREAT Prospective Study on Inflammatory Bowel DiseaseCompletedNCT05414578
• Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in SwitzerlandCompletedNCT05405465
• Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative ColitisStatus unknownNCT05404074Phase 1
• A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in PolandCompletedNCT05384080
• Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBDCompletedNCT05382897Not applicable
• A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative ColitisTerminatedNCT05382715
• Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)CompletedNCT05377840Not applicable
• A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative ColitisCompletedNCT05377580Phase 2
• Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)CompletedNCT05372939Phase 2
• VE202 in Patients With Mild-to-Moderate Ulcerative ColitisTerminatedNCT05370885Phase 2
• Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative ColitisStatus unknownNCT05341401Phase 2/3
• Ulcerative Colitis Mayo Score With Artificial IntelligenceStatus unknownNCT05336773
• The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBDStatus unknownNCT05321485Not applicable
• A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD TherapyActive, not recruitingNCT05316584Not applicable
• A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative ColitisWithdrawnNCT05316220Phase 3
• Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic EventsCompletedNCT05313620Phase 4
• Protein and Magnesium in Ulcerative ColitisStatus unknownNCT05271838Not applicable
• Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative ColitisCompletedNCT05271773
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT05242484Phase 2
• Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune DiseasesStatus unknownNCT05239702Early Phase 1
• Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical TrialStatus unknownNCT05230875
• Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult CareActive, not recruitingNCT05221281Not applicable
• Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis.CompletedNCT05219656
• Effect and Mechanism of Dopamine on Ulcerative ColitisCompletedNCT05214404
• Chronotherapy of 5-Aminosalicylic Acid in Ulcerative ColitisActive, not recruitingNCT05213234Not applicable
• Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative ColitisCompletedNCT05205603Phase 4
• Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel DiseaseCompletedNCT05194007Phase 2/3
• Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of KazakhstanStatus unknownNCT05189327
• The Nordic IBD Treatment Strategy TrialCompletedNCT05180175Phase 4
• Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisActive, not recruitingNCT05177835Phase 2
• Study of ExoFlo for the Treatment of Medically Refractory Ulcerative ColitisTerminatedNCT05176366Phase 1
• Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study)CompletedNCT05171634Not applicable
• Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative ColitisWithdrawnNCT05121402Phase 2
• Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative ColitisActive, not recruitingNCT05119140Phase 1/2
• A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative ColitisCompletedNCT05118919Phase 1/2
• Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory ComplicationsCompletedNCT05104723Phase 1/2
• Oral Health-related Quality of Life (OHRQoL) in Patients With Inflammatory Bowel Disease (IBD)CompletedNCT05096897
• A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsActive, not recruitingNCT05092269Phase 3
• An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)CompletedNCT05084261Phase 1
• Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative ColitisWithdrawnNCT05058417Phase 2
• Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With DepressionStatus unknownNCT05030064Not applicable
• West Hertfordshire Inflammatory Bowel Disease Technology StudyActive, not recruitingNCT05000242
• pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitisCompletedNCT04990245
• A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in SwitzerlandCompletedNCT04989907
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative ColitisTerminatedNCT04985968Phase 3
• GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA SurgeryStatus unknownNCT04979832Phase 1/2
• Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.CompletedNCT04969679Phase 4
• Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)TerminatedNCT04968951Early Phase 1

← Colitis, Ulcerative overview